ANI Pharmaceuticals Stock Forecast, Price & News

ANI Pharmaceuticals (NASDAQ:ANIP) Frequently Asked Questions

Is ANI Pharmaceuticals a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ANI Pharmaceuticals in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ANI Pharmaceuticals stock.
View analyst ratings for ANI Pharmaceuticals or view top-rated stocks.

How has ANI Pharmaceuticals' stock price been impacted by COVID-19?

ANI Pharmaceuticals' stock was trading at $38.30 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ANIP stock has increased by 7.0% and is now trading at $41.00.
View which stocks have been most impacted by COVID-19.

When is ANI Pharmaceuticals' next earnings date?

ANI Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, March 8th 2022.
View our earnings forecast for ANI Pharmaceuticals.

How were ANI Pharmaceuticals' earnings last quarter?

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) released its quarterly earnings data on Sunday, October, 31st. The specialty pharmaceutical company reported $1.01 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.70 by $0.31. The specialty pharmaceutical company earned $52.06 million during the quarter, compared to analyst estimates of $50.30 million. ANI Pharmaceuticals had a negative net margin of 10.40% and a positive trailing twelve-month return on equity of 17.80%. During the same quarter in the prior year, the business posted $0.70 earnings per share.
View ANI Pharmaceuticals' earnings history.

What price target have analysts set for ANIP?

2 analysts have issued twelve-month price targets for ANI Pharmaceuticals' shares. Their forecasts range from $65.00 to $70.00. On average, they anticipate ANI Pharmaceuticals' share price to reach $67.50 in the next year. This suggests a possible upside of 64.6% from the stock's current price.
View analysts' price targets for ANI Pharmaceuticals or view top-rated stocks among Wall Street analysts.

Who are ANI Pharmaceuticals' key executives?

ANI Pharmaceuticals' management team includes the following people:

• Nikhil Lalwani, President, Chief Executive Officer & Director
• James G. Marken, Senior VP-Operations & Product Development
• Stephen P. Carey, Chief Financial Officer, Secretary & VP
• Shanmugam Muthusamy, Director & Head-Research & Development
• Rob W. Schrepfer, SVP-New Business Development & Specialty Sales

What is Arthur Przbyl's approval rating as ANI Pharmaceuticals' CEO?

1 employees have rated ANI Pharmaceuticals CEO Arthur Przbyl on Glassdoor.com. Arthur Przbyl has an approval rating of 100% among ANI Pharmaceuticals' employees. This puts Arthur Przbyl in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of ANI Pharmaceuticals' key competitors?

Some companies that are related to ANI Pharmaceuticals include Sage Therapeutics (SAGE), I-Mab (IMAB), Indivior (INVVY), Arcus Biosciences (RCUS), EQRx (EQRX), Nuvation Bio (NUVB), Aurinia Pharmaceuticals (AUPH), Nektar Therapeutics (NKTR), Xencor (XNCR), Corcept Therapeutics (CORT), Harmony Biosciences (HRMY), Cryoport (CYRX), Schrödinger (SDGR), TG Therapeutics (TGTX) and Ligand Pharmaceuticals (LGND).
View all of ANIP's competitors.

What other stocks do shareholders of ANI Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ANI Pharmaceuticals investors own include Abraxas Petroleum (AXAS), Gilead Sciences (gild), Micron Technology (MU), AbbVie (ABBV), Teva Pharmaceutical Industries (TEVA), Alibaba Group (BABA), Broadcom (AVGO), Cisco Systems (CSCO), Exelixis (EXEL) and Intel (INTC).

What is ANI Pharmaceuticals' stock symbol?

ANI Pharmaceuticals trades on the NASDAQ under the ticker symbol "ANIP."

Who are ANI Pharmaceuticals' major shareholders?

ANI Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Russell Investments Group Ltd. (0.66%), State of Alaska Department of Revenue (0.05%), Collective Family Office LLC (0.04%) and Louisiana State Employees Retirement System (0.04%). Company insiders that own ANI Pharmaceuticals stock include Jeanne Thoma, Patrick D Walsh and Thomas Haughey.
View institutional ownership trends for ANI Pharmaceuticals.

Which institutional investors are selling ANI Pharmaceuticals stock?

ANIP stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd..
View insider buying and selling activity for ANI Pharmaceuticals or view top insider-selling stocks.

Which institutional investors are buying ANI Pharmaceuticals stock?

ANIP stock was bought by a variety of institutional investors in the last quarter, including Collective Family Office LLC, Louisiana State Employees Retirement System, and State of Alaska Department of Revenue. Company insiders that have bought ANI Pharmaceuticals stock in the last two years include Jeanne Thoma, Patrick D Walsh, and Thomas Haughey.
View insider buying and selling activity for ANI Pharmaceuticals or or view top insider-buying stocks.

How do I buy shares of ANI Pharmaceuticals?

Shares of ANIP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ANI Pharmaceuticals' stock price today?

One share of ANIP stock can currently be purchased for approximately $41.00.

How much money does ANI Pharmaceuticals make?

ANI Pharmaceuticals has a market capitalization of $583.88 million and generates $208.48 million in revenue each year. The specialty pharmaceutical company earns $-22.55 million in net income (profit) each year or ($1.83) on an earnings per share basis.

How many employees does ANI Pharmaceuticals have?

ANI Pharmaceuticals employs 369 workers across the globe.

What is ANI Pharmaceuticals' official website?

The official website for ANI Pharmaceuticals is www.anipharmaceuticals.com.

Where are ANI Pharmaceuticals' headquarters?

ANI Pharmaceuticals is headquartered at 210 Main Street West, Baudette MN, 56623.

How can I contact ANI Pharmaceuticals?

ANI Pharmaceuticals' mailing address is 210 Main Street West, Baudette MN, 56623. The specialty pharmaceutical company can be reached via phone at (218) 634-3500, via email at [email protected], or via fax at 218-634-3540.